Processing of the insulin-like growth factor-II-mannose 6-phosphate receptor in isolated liver subcellular fractions

Citation
K. Tahiri et al., Processing of the insulin-like growth factor-II-mannose 6-phosphate receptor in isolated liver subcellular fractions, BIOC CELL B, 79(4), 2001, pp. 469-477
Citations number
36
Categorie Soggetti
Cell & Developmental Biology
Journal title
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE
ISSN journal
08298211 → ACNP
Volume
79
Issue
4
Year of publication
2001
Pages
469 - 477
Database
ISI
SICI code
0829-8211(200108)79:4<469:POTIGF>2.0.ZU;2-H
Abstract
A truncated, soluble form of the insulin-like growth factor-II-mannose 6-ph osphate (IGF-II-M6P) receptor has been identified in serum and shown to be released from cultured tissues and cells, liver being the main contributor to serum receptor in adult rats. In the present study, the processing of th e IGF-II-M6P receptor has been characterized in isolated liver subcellular fractions using ligand binding, affinity crosslinking, and Western immunobl otting techniques. The receptor in plasma membrane fractions differed from that in Golgi-endosomal fractions by: (i) a lower molecular size upon reduc ing polyacrylamide gel electrophoresis (245 vs. 255 kDa); (ii) a less tight membrane association as judged upon extractibility by NaCl; and (iii) the inability to recognize antibody anti-22C, directed against the cytoplasmic domain of the receptor. Incubation of cell fractions at 30 degreesC led to a pH- and time-dependent release of the receptor into the medium. The pH op timum for release was 5.5 in the Golgi-endosomal fraction and 7.5 in plasma membrane fractions; at this pH, approximately 2% and 20%-30% of total rece ptors were released per hour, respectively. Receptor release was inhibited in a dose-dependent manner by aprotinin, benzamidine, and leupeptin in the Golgi-endosomal fraction, and by 1,10 phenanthroline in plasma membrane fra ctions, although high concentrations were required for inhibition. The rece ptor released from Golgi-endosomes showed a 5-10 kDa reduction in size and a loss of ability to recognize antibody anti-22C, but that released from pl asma membranes showed little or no changes in size. We conclude that solubl e, carboxy-terminally truncated forms of the IGF-II-M6P receptor are genera ted from the intact receptor in isolated Golgi-endosomal and plasma membran e fractions. However, receptor processing in these fractions exhibits diffe rent properties, suggesting the involvement of different proteases.